Vertex Pharmaceuticals Incorporated (VRTX)

185.67
NASDAQ
Prev Close 188.30
Day Low/High 185.07 / 188.89
52 Wk Low/High 184.78 / 280.99
Exchange NASDAQ
Shares Outstanding 259.43B
Market Cap 48.85B
P/E Ratio 23.27
Div & Yield N.A. (N.A)
Closing Bell: Barclays Bets on Alphabet Growth; Dow Falls, S&P 500 and Nasdaq Rise

Closing Bell: Barclays Bets on Alphabet Growth; Dow Falls, S&P 500 and Nasdaq Rise

A rally in crude oil gave rise to the energy sector in a mixed day of trading.

Vertex Pharmaceuticals Reaches Upside Price Target

Vertex Pharmaceuticals Reaches Upside Price Target

Base building pays off.

Vertex upgraded at BMO

Vertex upgraded at JMP

What You Must Know About Cystic Fibrosis Drug CTP-656

What You Must Know About Cystic Fibrosis Drug CTP-656

Acquiring CTP-656 from Concert Pharmaceuticals will only cost Vertex around $250 million.

Activist Investors Shake Up the Boards at Tiffany & Bristol-Myers Squibb

Activist Investors Shake Up the Boards at Tiffany & Bristol-Myers Squibb

Jana Partners are placing three members on Tiffany's board.

Vertex Pharmaceuticals to Rely on Acquisitions to Diversify Its Business

Vertex Pharmaceuticals to Rely on Acquisitions to Diversify Its Business

Vertex Pharmaceuticals will be weighing future acquisitions and partnerships to broaden is focus beyond cystic fibrosis.

Vertex Pharmaceuticals Sees Sales of Cystic Fibrosis Drug Lower Than Expected

Vertex Pharmaceuticals Sees Sales of Cystic Fibrosis Drug Lower Than Expected

Vertex Pharmaceuticals provided new financial guidance for 2017 on Sunday.

Here's What to Look for at the J.P. Morgan Healthcare Conference

Here's What to Look for at the J.P. Morgan Healthcare Conference

The biggest annual event for biotech and pharma investors starts Monday with the kickoff of the J.P. Morgan Healthcare Conference in San Francisco.

Cramer: Reviewing S&P's Hit-and-Miss Parade

Cramer: Reviewing S&P's Hit-and-Miss Parade

Even among the losers, buys are scarce.

More Base Building Ahead for Vertex Pharmaceuticals

More Base Building Ahead for Vertex Pharmaceuticals

Buy signals have not lasted more than two months, so far.

Vertex downgraded at Barclays

Bullish and Bearish Chart Reversals

Bullish and Bearish Chart Reversals

What stocks have changed direction in the past week.

5 Health Care Stocks Set to Bounce

5 Health Care Stocks Set to Bounce

These stocks are down some 20% over the last 30 months and look ripe for a rise.

A 'Semi-Charmed' Kind of NXPI Call Spread

A 'Semi-Charmed' Kind of NXPI Call Spread

It might be best to make this a late-afternoon purchase.

Cramer: How Did the Stock Market Get So Unwieldy?

The answer is that new data came out.

Charts Say Vertex Could Recover

Charts Say Vertex Could Recover

The rate of decline slowed into the base, just what chartists like to see. 

Vertex upgraded at Jefferies

Vertex upgraded at HC Wainwright

Vertex upgraded at Morgan Stanley

Vertex upgraded at Barclays

Stocks With Significant High Activity: the First Four Groups

Stocks With Significant High Activity: the First Four Groups

There are some good buying ideas among these stocks.

Vertex estimates, target cut at JMP

Corbus Ready to Take Cystic Fibrosis Drug the Distance Says CEO

Corbus Ready to Take Cystic Fibrosis Drug the Distance Says CEO

It’s been a hot M&A market for biotech companies developing treatments for rare diseases.

Can Biotechs' Relative Strength Be Trusted? 6 Stocks to Watch

Can Biotechs' Relative Strength Be Trusted? 6 Stocks to Watch

Sector may not be as bulletproof as we thought.

Cramer: I Like Receptos and Radius, as Well as the Four Horsemen

Cramer: I Like Receptos and Radius, as Well as the Four Horsemen

Jim Cramer answers viewers' stock questions from the floor of the New York Stock Exchange.

Picasso Painting Sells for a Record $179 Million Dollars at Auction

Picasso Painting Sells for a Record $179 Million Dollars at Auction

A Picasso Painting Fetched $179 million dollars at an auction at Christie's Monday night, the most ever paid for a work of art at auction.

3 Fantastic Pharmaceutical Stocks: Abbvie, Vertex and Biogen

3 Fantastic Pharmaceutical Stocks: Abbvie, Vertex and Biogen

AbbVie is a cheap stock and worries about competition immediately hurting its rheumatoid arthritis drug Humira are overblown, said John Schroer, Portfolio Manager for the AllianzGI Health Sciences Fund.

Earnings and Marriage Season

Earnings and Marriage Season

Biotech companies are saying, "I do."